The tremendous variation in human MHCII alleles is a barrier to using fluorophore-labeled peptide:MHCII tetramers to study antigen-specific CD4+ T cells. This is because matching of the MHCII molecule in the tetramer with each human subject is required. We show that fluorophore-labeled tetramers of peptides complexed t...
Shawn A. Mahmud, Grace D. Frechette, Lisa M. Burzenski et al.· JIM - Journal of Immunologic...· 0 citations
Our study identified an antigen (Ag)-specific CD4 T cell population in a preclinical orthotopic model of pancreatic ductal adenocarcinoma (PDA) that, upon expansion, elicited robust antitumor control. We developed an affinity-enhanced MHC-II tetramer to follow the endogenous tumor-specific CD4 T cells during pancreat...
Eduardo Cruz-Hinojoza, Zoe C. Schmichen, Sindri M. Bonner et al.· Cancer Research· 0 citations
T tumor-specific CD4 T cells are central mediators of effective immunotherapy in solid tumors, and human immunotherapy transcriptomics shows conserved Th1 programming and Treg destabilization as a feature of response.
Eduardo Cruz-Hinojoza, Zoe C. Schmiechen, Sindri M. Bonner et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.